Top psych stories of 2023: Physician burnout, ‘transformative’ psychedelics, more
Click Here to Manage Email Alerts
Some of the most-viewed stories on Healio Psychiatry over the past year highlighted the FDA designating an at-home depression treatment as a breakthrough device as well as the transformative power of psychedelics.
FDA warns against products with tianeptine
The FDA has issued a warning against the purchase or use of products that contain tianeptine, which has been illegally sold with claims to improve brain function and treat anxiety, depression, pain, opioid use disorder and other conditions. Read more.
Image: Adobe Stock
Physician burnout peaked during COVID
The AMA released a statement saying that the burnout rate among United States physicians spiked during the first 2 years of the COVID-19 pandemic, citing research published in Mayo Clinic Proceedings. Read More.
FDA grants breakthrough designation to at-home depression treatment
The regulatory body recognized the Finnish company, Sooma Medical, whose portable, patient-administered neuromodulation device employs a mild electrical current to stimulate targeted brain areas. Read more.
Psilocybin linked to positive effects on self-belief
Psilocybin therapy is associated with relaxed and revised negative self-beliefs that lead to acute neural entropy, according to a presenter from the American Society of Clinical Psychopharmacology annual meeting. Read more.
Lack of faith in system fueled physician burnout in 2022
U.S. physicians experienced more burnout and work-related stress in 2022 than in 2021, according to a survey of 500 doctors. Read more.
Anxiety, depression higher in remote workers
Rates of anxiety and depression were higher among people who worked remotely or in a hybrid setting compared with those who worked in-person, according to data from the U.S. Census Bureau’s Household Pulse Survey. Read more.
Psychedelics could be ‘transformative’ for health industry
Long-term treatment with psychedelics holds the potential to transform the health care industry through millions in savings, according to an expert at a congressional briefing hosted by Johns Hopkins University in November. Read more.
US suicide rates rise after 2 years of decline
Following 2 consecutive years of decline, total suicides in the U.S. rose from nearly 46,000 in 2020 to just over 48,000 in 2021, researchers wrote in a February edition of Morbidity and Mortality Weekly Report. Read more.
Study of ADHD therapeutic yields positive results
A Kansas-based biopharmaceutical company announced positive top-line results from a study on the effect of food on absorption of its investigational extended-release tablet therapeutic CTx-1301 to treat ADHD. Read more.
FDA clears investigational new drug application for cocaine use treatment
Tempero Bio, manufacturer of TMP-301, a treatment for cocaine use disorders, was also awarded a grant expected to total $5.3 million over the course of 2 years from the National Institute on Drug Abuse in support of its development. Read more.